NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and ...

PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...

Global Respiratory Inhalers Market Forecast2021-2031 (Value & Volume): - by Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others ...

GSK plc announced positive phase III data from its clinical programme to develop a next-generation version of its metered dose inhaler (MDI), Ventolin (salbutamol). Data confirm that the formulation ...

The most important advantage of inhaled delivery of medicines is that they are delivered directly into the airways and lungs, resulting in higher local concentrations, lower systemic exposure and ...

According to the report, the metered dose inhalers market was valued at $10.1 billion in 2024, and is estimated to reach $18.4 billion by 2034, growing at a CAGR of 6.2% from 2025 to 2034.

The genius of metered-dose inhaler design lies in its ability to generate a mist of medicine that can be breathed deeply into the lungs. Placing the inhaler into the mouth diminishes this effect ...

Please provide your email address to receive an email when new articles are posted on . The majority of patients demonstrated improper usage of epinephrine autoinjectors and metered-dose inhalers, ...

New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change. While these inhalers are critically important to saving lives and making it easier ...